Alice Mirante

Alice Mirante

Auto-generated profile, based on publicly available information

Alice Mirante

Hosp Pediatr Coimbra, Unidade Local Saude Coimbra, Unidade Endocrinol Pediat Diabet & Crescimento, Coimbra, Portugal

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MAMaria Inês Alvelos
Maria Inês Alvelos
IGIsabel Goncalves
Isabel Goncalves
ECEduarda Coutinho
Eduarda Coutinho
JAJoana Almeida
Joana Almeida
MBMargarida Bastos
Margarida Bastos
MLManuel Lemos
Manuel Lemos
Maturity-onset diabetes of the young (MODY) is a frequently misdiagnosed type of diabetes, which is characterized by early onset, autosomal dominant inheritance, and absence of insulin dependence. The most frequent subtypes are due to mutations of the GCK (MODY 2), HNF1A (MODY 3), and HNF4A (MODY 1) genes. We undertook the first multicenter genetic study of MODY in the Portuguese population. The GCK, HNF1A, and HNF4A genes were sequenced in 46 unrelated patients that had at least two of the three classical clinical criteria for MODY (age at diagnosis, family history, and clinical presentation). The functional consequences of the mutations were predicted by bioinformatics analysis. Mutations were identified in 23 (50%) families. Twelve families had mutations in the GCK gene, eight in the HNF1A gene, and three in the HNF4A gene. These included seven novel mutations (GCK c.494T>C, GCK c.563C>G, HNF1A c.1623G>A, HNF1A c.1729C>G, HNF4A c.68delG, HNF4A c.422G>C, HNF4A c.602A>C). Mutation-positive patients were younger at the time of diagnosis when compared to mutation-negative patients (14.3 vs. 23.0 years, p = 0.011). This study further expands the spectrum of known mutations associated with MODY, and may contribute to a better understanding of this type of diabetes and a more personalized clinical management of affected individuals.

19 March 2019 in Hormone Research in Paediatrics
Verified
Journal Article
Closed access
PDF file
RSRita Santos-Silva
Rita Santos-Silva
RCRita Cardoso
Rita Cardoso
LLLurdes Lopes
Lurdes Lopes
MFMarcelo Fonseca
Marcelo Fonseca
FEFilipa Espada
Filipa Espada
ODOn Behalf Of The Portuguese Society Of Pediatric Endocrinology And Diabetology
On Behalf Of The Portuguese Society Of Pediatric Endocrinology And Diabetology
Background: Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) is an autosomal recessive disorder characterized by 3 overlapping phenotypes: salt-wasting (SW), simple virilizing (SV), and non-classic (NC). We aimed at conducting a nationwide genotype description of the CAH pediatric patients and to establish their genotype–phenotype correlation. Methods: CAH patients were recruited from Portuguese pediatric endocrinology centers and classified as SW, SV, or NC. Genetic analysis was performed by polymerase chain reaction (sequence specific primer, restriction fragment length polymorphism) or direct Sanger sequencing. Genotypes were categorized into 4 groups (0, A, B, and C), according to their predicted enzymatic activity. In each group, the expected phenotype was compared to the observed phenotype to assess the genotype–phenotype correlation. Results: Our cohort comprises 212 unrelated pediatric CAH patients (29% SW, 11% SV, 60% NC). The most common pathogenic variant was p.(Val282Leu; 41.3% of the 424 alleles analyzed). The p.(Val282Leu) variant, together with c.293-13A/C>G, p.(Ile173Asn), p.(Leu308Thr), p.(Gln319*), and large deletions/conversions were responsible for 86.4% of the mutated alleles. Patients’ stratification by disease subtype revealed that the most frequent pathogenic variants were c.293-13A/C>G in SW (31.1%), p.(Ile173Asn) in SV (46.9%), and p.(Val282Leu) in NC (69.5%). The most common genotype was homozygosity for p.(Val282Leu; 33.0%). Moreover, we found 2 novel variants: p.(Ile161Thr) and p.(Trp202Arg), in exons 4 and 5, respectively. The global genotype-phenotype correlation was 92.4%. Group B (associated with the SV form) showed the lowest genotype–phenotype correlation (80%). Conclusion: Our cohort has one of the largest NC CAH pediatric populations described. We emphasize the high frequency of the p.(Val282Leu) variant and the very high genotype–phenotype correlation observed.

29 April 2024 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
FPFrancisca Puga
Francisca Puga
LCLaura Correia
Laura Correia
Inês VieiraInês Vieira
Inês Vieira
JCJoana Serra Caetano
Joana Serra Caetano
RCRita Cardoso
Rita Cardoso
AMAlice Mirante
Alice Mirante
Objective: Differentiated thyroid cancer (DTC) is the most common pediatric endocrine cancer but studies are scarce. Latest recommendations advocate for an individualized risk-based approach to select patients for additional therapy. Lymphovascular invasion is not considered, despite being a well-known risk factor in the adult population. The aim of this study was to describe the outcomes of a cohort of DTC patients diagnosed at pediatric age and to evaluate the impact of lymphovascular invasion on the risk of persistence/ recurrence. Methods: A retrospective study of patients diagnosed with DTC at pediatric age from 2010 to 2022 at a single center was performed. All patients had total thyroidectomy. Radioactive iodine therapy (RAI) was used in selected patients. The response to therapy and occurrence of persistent/recurrent disease were evaluated. Results: A total of 21 DTC were diagnosed, mostly papillary thyroid carcinoma (PTC) (81.0%, n=17). Six patients (28.6%) had nodal involvement and one (4.8%) had lung metastasis at the time of the diagnosis. Lymphovascular invasion was present in 11 patients (52.4%). After surgery, 13 patients (61.9%) underwent RAI. The mean follow-up time was 5.7 +/- 3.1 years. In total, 6 patients (31.6%) experienced persistent/recurrent disease during the follow-up time. Among PTC patients, persistent/recurrent disease was more frequent in the presence of lymphovascular invasion [55.6% (5/9) vs. 0.0% (0/6), p=0.031]. Conclusion: An individualized risk-based approach is recommended. Our study suggests that lymphovascular invasion may be associated with a higher risk of persistence/recurrence and should therefore be considered for decision making in children and adolescents with PTC.

25 August 2022 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
NBNádia Mourinho Bala
Nádia Mourinho Bala
RGRaquel S. Gonçalves
Raquel S. Gonçalves
JCJoana Serra Caetano
Joana Serra Caetano
RCRita Cardoso
Rita Cardoso
IDIsabel Dinis
Isabel Dinis
AMAlice Mirante
Alice Mirante
Objective: Primary adrenal insufficiency (PAI) is a rare condition in children, and is potentially life-threatening. The most common cause is congenital adrenal hyperplasia, and autoimmune etiology is the most frequent acquired cause in this age group. Symptoms are usually non-specific and, when suspected, investigation should include adrenocorticotropin hormone (ACTH) and morning serum cortisol measurement and, in some cases, a cosyntropin test to confirm the diagnosis. Prompt treatment is essential to prevent an adverse outcome. Methods: We retrospectively collected clinical and laboratory data from adrenal insufficiency due to autoimmune adrenalitis, observed from 2015 to 2020 in a pediatric endocrinology department of a tertiary care hospital. Results: Eight patients were identified, seven males and one female, with age at diagnosis between 14 and 17 years. The symptoms at presentation ranged from non-specific symptoms, such as chronic fatigue and weight loss, to a severe presentation, with altered mental status and seizures. The median duration of symptoms was 4.5 months. The diagnosis was confirmed by serum cortisol and plasma ACTH measurement and all were confirmed to have autoimmune etiology (positive anti-adrenal antibodies). At diagnosis, the most common laboratory abnormality was hyponatremia. All patients were treated with hydrocortisone and fludrocortisone. One patient presented with evidence of type 2 autoimmune polyglandular syndrome. Conclusion: PAI is a rare condition in the pediatric age group. Due to non-specific symptoms, a high index of suspicion is necessary to establish a prompt diagnosis. Once an autoimmune etiology is confirmed, it is important to initiate the appropriate treatment and search for signs and symptoms of other autoimmune diseases during follow-up.

1 May 2021 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
DSDiana Festas da Silva
Diana Festas da Silva
ALAdriana De Sousa Lages
Adriana De Sousa Lages
JCJoana Serra Caetano
Joana Serra Caetano
RCRita Cardoso
Rita Cardoso
IDIsabel Dinis
Isabel Dinis
AMAlice Mirante
Alice Mirante
Introduction: Hypoparathyroidism is characterized by low or inappropriately normal PTH production, hypocalcemia and hyperphosphatemia. Autosomal dominant hypocalcemia (ADH) type 1 is one of the genetic etiologies of this, caused by heterozygous activating mutations in the CASR gene. Some individuals fail to meet treatment goals despite standard therapy. Clinical Case: A 13-year-old male patient was admitted in the emergency department due to syncope during physical activity. There was no reference to seizures or other complaints. Standard screening for metabolic diseases revealed no changes at the 7th day of life and family history was unremarkable. There was a history of febrile seizures up to 5 years of age with several hospitalizations for diagnosis investigation that were inconclusive. Physical examination showed a positive Chvostek signal, without other changes. A basic workup revealed hypocalcemia 1.67mmol/L (NR: 2.19-2.66), hyperphosphatemia 3.06mmol/L (NR: 0.95-1.75), hypomagnesemia 0.62mmol/L (NR: 0.7-1.0), low 25Hydroxyvitamin D 8.7ng/mL (NR: >30ng/mL) and inappropriately low PTH 4.0pg/mL (NR: 16.0-87.0). Cranial computed tomography scan showed bilateral calcifications of the basal ganglia. Dual-energy x-ray absorptiometry revealed bone mineral density z-scores increased 15% in spine lumbar and decreased 7% in left femur. Cardiac ultrasound and electrocardiography were normal. The patient started therapy with intravenous calcium gluconate. During this treatment, he developed significant calcification of the peripheral veins at the site of administration, leading to intravenous therapy suspension. The dose of oral calcium, calcitriol and magnesium was gradually increased and sevelamer started to control hyperphosphatemia. Despite the optimization, the patient maintained hypocalcemia refractory to standard therapy. As a last resource strategy in therapeutic optimization, the patient started on rhPTH (1-34). Ever since, the patient has been clinically asymptomatic with biochemical stability and with a reasonable quality of life. At age 18, renal ultrasound revealed diffuse medullary nephrocalcinosis. The genetic testing revealed a novel variant c.368T>C p.(Leu123Ser) likely pathogenic in heterozygosity in the CASR gene, suggesting the diagnosis of ADH type 1. The patient′s mother did not give her consent for genetic study and patient’s father had already died with a diagnosis of acute leukemia. Conclusion: This case can be explained by the presence of a likely pathogenic variant in heterozygosity in the CASR gene that has been described in the medical literature that has not been identified in gnomAD population database, suggesting the diagnosis of ADH type 1. rhPTH (1-34) may be a treatment option for those individuals who are not well controlled on standard therapy, but long-term follow-up studies are needed to reinforce its safety.

16 July 2021
Verified
Journal Article
Open access
RPRaquel Penteado
Raquel Penteado
GSGustavo Bento Soares
Gustavo Bento Soares
SSSérgio Sousa
Sérgio Sousa
AMAlice Mirante
Alice Mirante
NMNúria Madureira
Núria Madureira
Introduction - Achondroplasia is the most common bone dysplasia and is associated with extreme, disproportionate shortness of stature. Early care is essential to identify risks and prevent serious sequelae. The American Academy of Pediatrics recommends conducting a polysomnography soon after the diagnosis of achondroplasia. Materials and Methods - A retrospective study of children with achondroplasia referred to the multidisciplinary consultation in a central hospital in the first two years of life, between 2015 and the end of the first semester of 2020. Results - Ten children with achondroplasia were referred. The first evaluation in a pneumology consultation occurred between 3 and 22 months. Four children presented with snoring. The polysomnography was carried out between 5 and 26 months, revealing obstructive sleep apnoea syndrome in seven children (including one with no snoring). The five with moderate/severe obstructive sleep apnoea syndrome were started on non-invasive ventilation. All of them maintain non-invasive ventilation, most with good adherence. One of the children underwent an adenotonsillectomy at 2 years of age and maintains ventilation. Magnetic resonance imaging of the brain showed stenosis of the foramen magnum in all children. In the nine children who did a polysomnography with no previous neurosurgical intervention, the rate of central apnoea was normal. Discussion - The prevalence and the severity of obstructive sleep-disordered breathing in children with achondroplasia, especially in the first two years of life, justifies early referral of these patients. Non-invasive ventilation was the most frequently used therapy and constitutes a valid and effective therapeutic option.